within Pharmacolibrary.Drugs.ATC.A;

model A06AX05
  extends Pharmacokinetic.Models.PK_2C_enteral(
    weight         = 70,
    F              = 0.93,
    Cl             = 0.000285,
    adminDuration  = 600,
    adminMass      = 2 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.567,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.021833333333333333,
    Tlag           = 15.600000000000001,            
    Vdp             = 0.187,
    k12             = 57.7,
    k21             = 57.7
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>A06AX05</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Prucalopride is a selective, high-affinity serotonin 5-HT4 receptor agonist, primarily used for the treatment of chronic idiopathic constipation in adults when laxatives fail to provide adequate relief. It stimulates colonic peristalsis, leading to increased bowel movements. Prucalopride is approved and used in many countries.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetics in healthy adult subjects (mixed sex), following multiple oral dosing.</p><h4>References</h4><ol><li><p>Van de Velde, V, et al., &amp; Ausma, J (2013). Effect of prucalopride on the pharmacokinetics of oral contraceptives in healthy women. <i>Drugs in R&amp;D</i> 13(1) 43–51. DOI:<a href=\"https://doi.org/10.1007/s40268-013-0008-6\">10.1007/s40268-013-0008-6</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/23539257/\">https://pubmed.ncbi.nlm.nih.gov/23539257</a></p></li><li><p>Chen, X, et al., &amp; Hu, P (2012). Pharmacokinetics of single and repeated oral doses prucalopride in healthy Chinese volunteers. <i>International journal of clinical pharmacology and therapeutics</i> 50(11) 797–804. DOI:<a href=\"https://doi.org/10.5414/CP201769\">10.5414/CP201769</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/22943932/\">https://pubmed.ncbi.nlm.nih.gov/22943932</a></p></li><li><p>Flach, S, et al., &amp; Getsy, J (2016). A Phase I Study to Investigate the Absorption, Pharmacokinetics, and Excretion of [(14)C]Prucalopride After a Single Oral Dose in Healthy Volunteers. <i>Clinical therapeutics</i> 38(9) 2106–2115. DOI:<a href=\"https://doi.org/10.1016/j.clinthera.2016.08.003\">10.1016/j.clinthera.2016.08.003</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/27614912/\">https://pubmed.ncbi.nlm.nih.gov/27614912</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end A06AX05;
